FLUENT (FNT.U) Stock Overview
Through its subsidiaries, cultivates, manufactures processes, distributes, and sells medical cannabis products for medical and adult-use markets in Florida, New York, Pennsylvania, and Texas. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
FNT.U Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
FLUENT Corp. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.05 |
| 52 Week High | US$0.12 |
| 52 Week Low | US$0.04 |
| Beta | 0.91 |
| 1 Month Change | -9.09% |
| 3 Month Change | -28.57% |
| 1 Year Change | -52.38% |
| 3 Year Change | -70.59% |
| 5 Year Change | -86.11% |
| Change since IPO | -97.44% |
Recent News & Updates
FLUENT Corp.'s (CSE:FNT.U) 33% Dip In Price Shows Sentiment Is Matching Revenues
Sep 11
FLUENT Corp. (CSE:FNT.U) Stock Rockets 56% As Investors Are Less Pessimistic Than Expected
Jul 12Recent updates
FLUENT Corp.'s (CSE:FNT.U) 33% Dip In Price Shows Sentiment Is Matching Revenues
Sep 11FLUENT Corp. (CSE:FNT.U) Stock Rockets 56% As Investors Are Less Pessimistic Than Expected
Jul 12It's A Story Of Risk Vs Reward With FLUENT Corp. (CSE:FNT.U)
May 28Slammed 29% Cansortium Inc. (CSE:TIUM.U) Screens Well Here But There Might Be A Catch
Dec 27Cansortium Inc. (CSE:TIUM.U) Stock's 38% Dive Might Signal An Opportunity But It Requires Some Scrutiny
Nov 07Cansortium (CSE:TIUM.U) Seems To Be Using A Lot Of Debt
Oct 25Cansortium Inc. (CSE:TIUM.U) Soars 30% But It's A Story Of Risk Vs Reward
Sep 04Cansortium Inc.'s (CSE:TIUM.U) CEO Compensation Is Looking A Bit Stretched At The Moment
Aug 21Slammed 32% Cansortium Inc. (CSE:TIUM.U) Screens Well Here But There Might Be A Catch
Jul 11Cansortium Inc.'s (CSE:TIUM.U) Shares Not Telling The Full Story
Jan 15Is Cansortium (CSE:TIUM.U) Using Too Much Debt?
Nov 30Is Cansortium (CSE:TIUM.U) Using Debt Sensibly?
Sep 01Cansortium Inc. (CSE:TIUM.U) Looks Inexpensive After Falling 30% But Perhaps Not Attractive Enough
Jul 28An Intrinsic Calculation For Cansortium Inc. (CSE:TIUM.U) Suggests It's 26% Undervalued
Mar 08Does Cansortium (CSE:TIUM.U) Have A Healthy Balance Sheet?
Jan 09Here's Why Cansortium (CSE:TIUM.U) Has A Meaningful Debt Burden
Sep 09Shareholder Returns
| FNT.U | CA Pharmaceuticals | CA Market | |
|---|---|---|---|
| 7D | 0% | -6.9% | -0.8% |
| 1Y | -52.4% | -15.8% | 16.1% |
Return vs Industry: FNT.U underperformed the Canadian Pharmaceuticals industry which returned -9.3% over the past year.
Return vs Market: FNT.U underperformed the Canadian Market which returned 17.7% over the past year.
Price Volatility
| FNT.U volatility | |
|---|---|
| FNT.U Average Weekly Movement | 19.1% |
| Pharmaceuticals Industry Average Movement | 11.9% |
| Market Average Movement | 9.9% |
| 10% most volatile stocks in CA Market | 20.0% |
| 10% least volatile stocks in CA Market | 3.0% |
Stable Share Price: FNT.U's share price has been volatile over the past 3 months compared to the Canadian market.
Volatility Over Time: FNT.U's weekly volatility (19%) has been stable over the past year, but is still higher than 75% of Canadian stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2018 | 826 | Dave Vautrin | getfluent.com |
FLUENT Corp., through its subsidiaries, cultivates, manufactures processes, distributes, and sells medical cannabis products for medical and adult-use markets in Florida, New York, Pennsylvania, and Texas. The company’s medical cannabis products are offered in oral drops, capsules, topicals, syringes, dried flower, pre-rolls, cartridges, concentrates, edibles, and other accessories under the Fluent brand name. It also sells various third-party branded medical cannabis products.
FLUENT Corp. Fundamentals Summary
| FNT.U fundamental statistics | |
|---|---|
| Market cap | US$35.05m |
| Earnings (TTM) | -US$55.60m |
| Revenue (TTM) | US$104.51m |
Is FNT.U overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| FNT.U income statement (TTM) | |
|---|---|
| Revenue | US$104.51m |
| Cost of Revenue | US$62.66m |
| Gross Profit | US$41.86m |
| Other Expenses | US$97.45m |
| Earnings | -US$55.60m |
Last Reported Earnings
Jun 30, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.087 |
| Gross Margin | 40.05% |
| Net Profit Margin | -53.19% |
| Debt/Equity Ratio | -288.3% |
How did FNT.U perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/11/06 09:19 |
| End of Day Share Price | 2025/11/06 00:00 |
| Earnings | 2025/06/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
FLUENT Corp. is covered by 5 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Russell Stanley | Beacon Securities Limited |
| Jonathan DeCourcey | BTIG |
| Robert Burleson | Canaccord Genuity |